Cordycepin inhibits LPS-induced acute lung injury by inhibiting inflammatory response

Xian Jiang; Xian Jiang; Zhuo Zhang; Zhuo Zhang; Fang Wang; Fang Wang; Siwei Chen; Siwei Chen; Xiaobin Wang; Xiaobin Wang; Jicheng Wei; Jicheng Wei

doi:10.18632/oncotarget.23775

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Withdrawal Notice

This paper was originally published in Oncotarget Advance Online Publications on 01/01/2018.
In compliance with Oncotarget's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Oncotarget internal or any external indexes or archives.

Research Papers:

Cordycepin inhibits LPS-induced acute lung injury by inhibiting inflammatory response

Xian Jiang, Xian Jiang, Zhuo Zhang, Zhuo Zhang, Fang Wang, Fang Wang, Siwei Chen, Siwei Chen, Xiaobin Wang, Xiaobin Wang, Jicheng Wei _ and Jicheng Wei _

Xian Jiang1, Zhuo Zhang2, Fang Wang3, Siwei Chen4, Xiaobin Wang1 and Jicheng Wei1

1 Department of anesthesiology, The Affiliated Hospital of College of pharmacy, Southwest medical university, Luzhou, Sichuan, China

2 Laboratory of pharmacology, College of pharmacy, Southwest medical university, Luzhou, Sichuan, China

3 Laboratory of Pharmaceutics, College of pharmacy, Southwest medical university, Luzhou, Sichuan, China

4 Laboratory of Science of Chinese Pharmacology, College of pharmacy, Southwest medical university, Luzhou, Sichuan, China

Correspondence:

Jicheng Wei, email: [email protected]

Keywords: cordycepin; LPS; lung injury; NLRP3; NF-κB

Received: August 23, 2017 Accepted: December 16, 2017 Epub: January 01, 2018

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 23775

Publication Alerts

Withdrawal Notice

Research Papers:

Cordycepin inhibits LPS-induced acute lung injury by inhibiting inflammatory response